{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T06:51:40Z","timestamp":1794293500843,"version":"4.9.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T00:00:00Z","timestamp":1739232000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T00:00:00Z","timestamp":1739232000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Science and Technology Council, Taiwan"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Ubiquitination is a posttranslational modification that regulates tumour progression-associated proteins through the ubiquitin\u2012proteasome system, making E3 ligases potential antitumour targets. Here, we report that TRIM8, a member of the TRIM family and an E3 ligase, can act as a tumour suppressor in non-small cell lung cancer (NSCLC). Both gain- and loss-of-function experiments revealed that TRIM8 inhibits the proliferation, colony formation, migration and invasion of NSCLC cells. Experiments with a xenograft model showed that TRIM8 expression suppresses tumour metastasis in vivo. Moreover, low expression of TRIM8 was associated with poor overall survival in both the Taiwanese and GEO lung cancer cohorts. TRIM8 overexpression in lung cancer cells reduced MYOF expression, and restoring MYOF rescued cell migration in TRIM8-overexpressing cells. TRIM8 targeted MYOF for K48-linked ubiquitination, facilitating proteasome-mediated degradation and subsequently suppressing the extracellular secretion of MMPs. Our results provide new insights into the contribution of TRIM8 to lung cancer progression, suggesting that TRIM8 is a new biomarker and a novel therapeutic target for lung cancer.<\/jats:p>","DOI":"10.1038\/s41419-025-07421-6","type":"journal-article","created":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T17:27:01Z","timestamp":1739294821000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["E3 ligase TRIM8 suppresses lung cancer metastasis by targeting MYOF degradation through K48-linked polyubiquitination"],"prefix":"10.1038","volume":"16","author":[{"given":"Chi-Hsuan","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4842-7308","authenticated-orcid":false,"given":"Chia-Wei","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Ying","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsuan-Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Hsuan","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gee-Chen","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1049-3825","authenticated-orcid":false,"given":"Jeremy J. W.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,11]]},"reference":[{"key":"7421_CR1","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-019-0770-x","volume":"21","author":"PR Halliday","year":"2019","unstructured":"Halliday PR, Blakely CM, Bivona TG. Emerging targeted therapies for the treatment of non-small cell lung cancer. Curr Oncol Rep. 2019;21:21.","journal-title":"Curr Oncol Rep."},{"key":"7421_CR2","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/nature25183","volume":"553","author":"RS Herbst","year":"2018","unstructured":"Herbst RS, Morgensztern D, Boshoff C. The biology and management of non-small cell lung cancer. Nature. 2018;553:446\u201354.","journal-title":"Nature"},{"key":"7421_CR3","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41568-018-0081-9","volume":"19","author":"NK Altorki","year":"2019","unstructured":"Altorki NK, Markowitz GJ, Gao D, Port JL, Saxena A, Stiles B, et al. The lung microenvironment: an important regulator of tumour growth and metastasis. Nat Rev Cancer. 2019;19:9\u201331.","journal-title":"Nat Rev Cancer"},{"key":"7421_CR4","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/nrclinonc.2017.101","volume":"14","author":"WH Fridman","year":"2017","unstructured":"Fridman WH, Zitvogel L, Sautes-Fridman C, Kroemer G. The immune contexture in cancer prognosis and treatment. Nat Rev Clin Oncol. 2017;14:717\u201334.","journal-title":"Nat Rev Clin Oncol"},{"key":"7421_CR5","doi-asserted-by":"publisher","first-page":"15.","DOI":"10.3390\/medicina56010015","volume":"56","author":"B Arneth","year":"2019","unstructured":"Arneth B. Tumor microenvironment. Medicina (Kaunas). 2019;56:15.","journal-title":"Medicina (Kaunas)"},{"key":"7421_CR6","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1111\/febs.14343","volume":"285","author":"P Jeannin","year":"2018","unstructured":"Jeannin P, Paolini L, Adam C, Delneste Y. The roles of CSFs on the functional polarization of tumor-associated macrophages. FEBS J. 2018;285:680\u201399.","journal-title":"FEBS J"},{"key":"7421_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/srep14273","volume":"5","author":"A Yuan","year":"2015","unstructured":"Yuan A, Hsiao YJ, Chen HY, Chen HW, Ho CC, Chen YY, et al. Opposite effects of M1 and M2 macrophage subtypes on lung cancer progression. Sci Rep. 2015;5:14273.","journal-title":"Sci Rep."},{"key":"7421_CR8","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1038\/jid.2008.310","volume":"129","author":"JW Tjiu","year":"2009","unstructured":"Tjiu JW, Chen JS, Shun CT, Lin SJ, Liao YH, Chu CY, et al. Tumor-associated macrophage-induced invasion and angiogenesis of human basal cell carcinoma cells by cyclooxygenase-2 induction. J Invest Dermatol. 2009;129:1016\u201325.","journal-title":"J Invest Dermatol"},{"key":"7421_CR9","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s43556-021-00043-2","volume":"2","author":"Q Yang","year":"2021","unstructured":"Yang Q, Zhao J, Chen D, Wang Y. E3 ubiquitin ligases: styles, structures and functions. Mol Biomed. 2021;2:23.","journal-title":"Mol Biomed"},{"key":"7421_CR10","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1007\/s10753-016-0491-3","volume":"40","author":"L Guo","year":"2017","unstructured":"Guo L, Dong W, Fu X, Lin J, Dong Z, Tan X, et al. Tripartite Motif 8 (TRIM8) positively regulates pro-inflammatory responses in pseudomonas aeruginosa-induced keratitis through promoting K63-linked polyubiquitination of TAK1 protein. Inflammation. 2017;40:454\u201363.","journal-title":"Inflammation"},{"key":"7421_CR11","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.4049\/jimmunol.1601647","volume":"199","author":"W Ye","year":"2017","unstructured":"Ye W, Hu MM, Lei CQ, Zhou Q, Lin H, Sun MS, et al. TRIM8 negatively regulates TLR3\/4-mediated innate immune response by blocking TRIF-TBK1 interaction. J Immunol. 2017;199:1856\u201364.","journal-title":"J Immunol"},{"key":"7421_CR12","first-page":"3440","volume":"10","author":"Z Tian","year":"2020","unstructured":"Tian Z, Tang J, Liao X, Gong Y, Yang Q, Wu Y, et al. TRIM8 inhibits breast cancer proliferation by regulating estrogen signaling. Am J Cancer Res. 2020;10:3440\u201357.","journal-title":"Am J Cancer Res"},{"key":"7421_CR13","doi-asserted-by":"publisher","first-page":"511","DOI":"10.4161\/cc.11.3.19008","volume":"11","author":"MF Caratozzolo","year":"2012","unstructured":"Caratozzolo MF, Micale L, Turturo MG, Cornacchia S, Fusco C, Marzano F, et al. TRIM8 modulates p53 activity to dictate cell cycle arrest. Cell Cycle. 2012;11:511\u201323.","journal-title":"Cell Cycle"},{"key":"7421_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-017-0634-7","volume":"16","author":"F Mastropasqua","year":"2017","unstructured":"Mastropasqua F, Marzano F, Valletti A, Aiello I, Di Tullio G, Morgano A, et al. TRIM8 restores p53 tumour suppressor function by blunting N-MYC activity in chemo-resistant tumours. Mol Cancer. 2017;16:67.","journal-title":"Mol Cancer"},{"key":"7421_CR15","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-020-01447-w","volume":"38","author":"J Majidpoor","year":"2021","unstructured":"Majidpoor J, Mortezaee K. Steps in metastasis: an updated review. Med Oncol. 2021;38:3.","journal-title":"Med Oncol"},{"key":"7421_CR16","doi-asserted-by":"publisher","first-page":"4081","DOI":"10.1038\/sj.onc.1208573","volume":"24","author":"CC Wang","year":"2005","unstructured":"Wang CC, Tsai MF, Hong TM, Chang GC, Chen CY, Yang WM, et al. The transcriptional factor YY1 upregulates the novel invasion suppressor HLJ1 expression and inhibits cancer cell invasion. Oncogene. 2005;24:4081\u201393.","journal-title":"Oncogene"},{"key":"7421_CR17","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1038\/s41374-018-0057-0","volume":"98","author":"DK Meyerholz","year":"2018","unstructured":"Meyerholz DK, Beck AP. Principles and approaches for reproducible scoring of tissue stains in research. Lab Invest. 2018;98:844\u201355.","journal-title":"Lab Invest"},{"key":"7421_CR18","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","volume":"30","author":"AM Bolger","year":"2014","unstructured":"Bolger AM, Lohse M, Usadel B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics. 2014;30:2114\u201320.","journal-title":"Bioinformatics"},{"key":"7421_CR19","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/s41587-019-0201-4","volume":"37","author":"D Kim","year":"2019","unstructured":"Kim D, Paggi JM, Park C, Bennett C, Salzberg SL. Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype. Nat Biotechnol. 2019;37:907\u201315.","journal-title":"Nat Biotechnol"},{"key":"7421_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00050-4","volume":"8","author":"SME Sahraeian","year":"2017","unstructured":"Sahraeian SME, Mohiyuddin M, Sebra R, Tilgner H, Afshar PT, Au KF, et al. Gaining comprehensive biological insight into the transcriptome by performing a broad-spectrum RNA-seq analysis. Nat Commun. 2017;8:59.","journal-title":"Nat Commun"},{"key":"7421_CR21","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","volume":"30","author":"Y Liao","year":"2014","unstructured":"Liao Y, Smyth GK, Shi W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics. 2014;30:923\u201330.","journal-title":"Bioinformatics"},{"key":"7421_CR22","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1093\/bioinformatics\/btp612","volume":"26","author":"L Wang","year":"2010","unstructured":"Wang L, Feng Z, Wang X, Wang X, Zhang X. DEGseq: an R package for identifying differentially expressed genes from RNA-seq data. Bioinformatics. 2010;26:136\u20138.","journal-title":"Bioinformatics"},{"key":"7421_CR23","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nprot.2008.211","volume":"4","author":"W Huang da","year":"2009","unstructured":"Huang da W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4:44\u201357.","journal-title":"Nat Protoc"},{"key":"7421_CR24","doi-asserted-by":"publisher","first-page":"W216","DOI":"10.1093\/nar\/gkac194","volume":"50","author":"BT Sherman","year":"2022","unstructured":"Sherman BT, Hao M, Qiu J, Jiao X, Baseler MW, Lane HC, et al. DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update). Nucleic Acids Res. 2022;50:W216\u201321.","journal-title":"Nucleic Acids Res"},{"key":"7421_CR25","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1093\/bioinformatics\/18.1.207","volume":"18","author":"A Sturn","year":"2002","unstructured":"Sturn A, Quackenbush J, Trajanoski Z. Genesis: cluster analysis of microarray data. Bioinformatics. 2002;18:207\u20138.","journal-title":"Bioinformatics"},{"key":"7421_CR26","unstructured":"Oliveros JC Venny. An interactive tool for comparing lists with Venn\u2019s diagrams. Publicly available at http:\/\/bioinfogp.cnb.csic.es\/tools\/venny\/index.html. 2007\u20132015."},{"key":"7421_CR27","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1111\/bph.16257","volume":"181","author":"B Gyorffy","year":"2024","unstructured":"Gyorffy B. Transcriptome-level discovery of survival-associated biomarkers and therapy targets in non-small-cell lung cancer. Br J Pharmacol. 2024;181:362\u201374.","journal-title":"Br J Pharmacol"},{"key":"7421_CR28","doi-asserted-by":"publisher","first-page":"e10312","DOI":"10.1371\/journal.pone.0010312","volume":"5","author":"J Hou","year":"2010","unstructured":"Hou J, Aerts J, den Hamer B, van Ijcken W, den Bakker M, Riegman P, et al. Gene expression-based classification of non-small cell lung carcinomas and survival prediction. PLoS One. 2010;5:e10312.","journal-title":"PLoS One"},{"key":"7421_CR29","doi-asserted-by":"publisher","first-page":"186ra66","DOI":"10.1126\/scitranslmed.3005723","volume":"5","author":"S Rousseaux","year":"2013","unstructured":"Rousseaux S, Debernardi A, Jacquiau B, Vitte AL, Vesin A, Nagy-Mignotte H, et al. Ectopic activation of germline and placental genes identifies aggressive metastasis-prone lung cancers. Sci Transl Med. 2013;5:186ra66.","journal-title":"Sci Transl Med"},{"key":"7421_CR30","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1158\/0008-5472.CAN-11-1403","volume":"72","author":"H Okayama","year":"2012","unstructured":"Okayama H, Kohno T, Ishii Y, Shimada Y, Shiraishi K, Iwakawa R, et al. Identification of genes upregulated in ALK-positive and EGFR\/KRAS\/ALK-negative lung adenocarcinomas. Cancer Res. 2012;72:100\u201311.","journal-title":"Cancer Res"},{"key":"7421_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06179-0","volume":"9","author":"T Zhang","year":"2018","unstructured":"Zhang T, Li J, He Y, Yang F, Hao Y, Jin W, et al. A small molecule targeting myoferlin exerts promising anti-tumor effects on breast cancer. Nat Commun. 2018;9:3726.","journal-title":"Nat Commun"},{"key":"7421_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-48968-7","volume":"9","author":"HJ An","year":"2019","unstructured":"An HJ, Song DH, Koh HM, Kim YM, Ko GH, Lee JH, et al. Myoferlin silencing inhibits VEGFR2-mediated proliferation of metastatic clear cell renal cell carcinoma. Sci Rep. 2019;9:12656.","journal-title":"Sci Rep."},{"key":"7421_CR33","doi-asserted-by":"publisher","first-page":"4398","DOI":"10.1038\/s41388-018-0287-z","volume":"37","author":"G Rademaker","year":"2018","unstructured":"Rademaker G, Hennequiere V, Brohee L, Nokin MJ, Lovinfosse P, Durieux F, et al. Myoferlin controls mitochondrial structure and activity in pancreatic ductal adenocarcinoma, and affects tumor aggressiveness. Oncogene. 2018;37:4398\u2013412.","journal-title":"Oncogene"},{"key":"7421_CR34","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1111\/jcmm.13455","volume":"22","author":"W Zhang","year":"2018","unstructured":"Zhang W, Zhou P, Meng A, Zhang R, Zhou Y. Down-regulating Myoferlin inhibits the vasculogenic mimicry of melanoma via decreasing MMP-2 and inducing mesenchymal-to-epithelial transition. J Cell Mol Med. 2018;22:1743\u201354.","journal-title":"J Cell Mol Med"},{"key":"7421_CR35","doi-asserted-by":"publisher","first-page":"20078","DOI":"10.1073\/pnas.1116327108","volume":"108","author":"MC Eisenberg","year":"2011","unstructured":"Eisenberg MC, Kim Y, Li R, Ackerman WE, Kniss DA, Friedman A. Mechanistic modeling of the effects of myoferlin on tumor cell invasion. Proc Natl Acad Sci USA. 2011;108:20078\u201383.","journal-title":"Proc Natl Acad Sci USA"},{"key":"7421_CR36","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1136\/annrheumdis-2020-217470","volume":"80","author":"GS Schulert","year":"2021","unstructured":"Schulert GS, Pickering AV, Do T, Dhakal S, Fall N, Schnell D, et al. Monocyte and bone marrow macrophage transcriptional phenotypes in systemic juvenile idiopathic arthritis reveal TRIM8 as a mediator of IFN-gamma hyper-responsiveness and risk for macrophage activation syndrome. Ann Rheum Dis. 2021;80:617\u201325.","journal-title":"Ann Rheum Dis"},{"key":"7421_CR37","doi-asserted-by":"publisher","first-page":"963689720943604","DOI":"10.1177\/0963689720943604","volume":"29","author":"R Liu","year":"2020","unstructured":"Liu R, Wu H, Song H. Knockdown of TRIM8 Attenuates IL-1beta-induced Inflammatory Response in Osteoarthritis Chondrocytes Through the Inactivation of NF-kappaB Pathway. Cell Transplant. 2020;29:963689720943604.","journal-title":"Cell Transplant"},{"key":"7421_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-021-01913-z","volume":"21","author":"TJ Chen","year":"2021","unstructured":"Chen TJ, Zheng Q, Gao F, Yang T, Ren H, Li Y, et al. MicroRNA-665 facilitates cell proliferation and represses apoptosis through modulating Wnt5a\/beta-Catenin and Caspase-3 signaling pathways by targeting TRIM8 in LUSC. Cancer Cell Int. 2021;21:215.","journal-title":"Cancer Cell Int"},{"key":"7421_CR39","doi-asserted-by":"publisher","first-page":"4973","DOI":"10.2147\/DDDT.S333372","volume":"15","author":"BH Zhang","year":"2021","unstructured":"Zhang BH, Liu H, Yuan Y, Weng XD, Du Y, Chen H, et al. Knockdown of TRIM8 protects HK-2 cells against hypoxia\/reoxygenation-induced injury by inhibiting oxidative stress-mediated apoptosis and pyroptosis via PI3K\/Akt signal pathway. Drug Des Devel Ther. 2021;15:4973\u201383.","journal-title":"Drug Des Devel Ther"},{"key":"7421_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-015-1449-9","volume":"15","author":"L Micale","year":"2015","unstructured":"Micale L, Fusco C, Fontana A, Barbano R, Augello B, De Nittis P, et al. TRIM8 downregulation in glioma affects cell proliferation and it is associated with patients survival. BMC Cancer. 2015;15:470.","journal-title":"BMC Cancer"},{"key":"7421_CR41","doi-asserted-by":"publisher","first-page":"998","DOI":"10.3892\/ol.2015.3988","volume":"11","author":"DH Song","year":"2016","unstructured":"Song DH, Ko GH, Lee JH, Lee JS, Lee GW, Kim HC, et al. Myoferlin expression in non-small cell lung cancer: Prognostic role and correlation with VEGFR-2 expression. Oncol Lett. 2016;11:998\u20131006.","journal-title":"Oncol Lett"},{"key":"7421_CR42","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1002\/ijc.29820","volume":"138","author":"K Fahmy","year":"2016","unstructured":"Fahmy K, Gonzalez A, Arafa M, Peixoto P, Bellahcene A, Turtoi A, et al. Myoferlin plays a key role in VEGFA secretion and impacts tumor-associated angiogenesis in human pancreas cancer. Int J Cancer. 2016;138:652\u201363.","journal-title":"Int J Cancer"},{"key":"7421_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.621810","volume":"9","author":"M Li","year":"2021","unstructured":"Li M, Peng F, Wang G, Liang X, Shao M, Chen Z, et al. Coupling of cell surface biotinylation and SILAC-based quantitative proteomics identified myoferlin as a potential therapeutic target for nasopharyngeal carcinoma metastasis. Front Cell Dev Biol. 2021;9:621810.","journal-title":"Front Cell Dev Biol"},{"key":"7421_CR44","doi-asserted-by":"publisher","first-page":"e86110","DOI":"10.1371\/journal.pone.0086110","volume":"9","author":"LI Volakis","year":"2014","unstructured":"Volakis LI, Li R, Ackerman WEt, Mihai C, Bechel M, Summerfield TL, et al. Loss of myoferlin redirects breast cancer cell motility towards collective migration. PLoS One. 2014;9:e86110.","journal-title":"PLoS One"},{"key":"7421_CR45","doi-asserted-by":"publisher","first-page":"3708","DOI":"10.1038\/s41388-023-02879-0","volume":"42","author":"L Wang","year":"2023","unstructured":"Wang L, Li H, Huang A, Zhao Y, Xiao C, Dong J, et al. Mutual regulation between TRIM21 and TRIM8 via K48-linked ubiquitination. Oncogene. 2023;42:3708\u201318.","journal-title":"Oncogene"},{"key":"7421_CR46","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aax3511","volume":"5","author":"G Maarifi","year":"2019","unstructured":"Maarifi G, Smith N, Maillet S, Moncorge O, Chamontin C, Edouard J, et al. TRIM8 is required for virus-induced IFN response in human plasmacytoid dendritic cells. Sci Adv. 2019;5:eaax3511.","journal-title":"Sci Adv"},{"key":"7421_CR47","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.1242\/jcs.068981","volume":"123","author":"F Okumura","year":"2010","unstructured":"Okumura F, Matsunaga Y, Katayama Y, Nakayama KI, Hatakeyama S. TRIM8 modulates STAT3 activity through negative regulation of PIAS3. J Cell Sci. 2010;123:2238\u201345.","journal-title":"J Cell Sci"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07421-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07421-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07421-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T17:27:05Z","timestamp":1739294825000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07421-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,11]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7421"],"URL":"https:\/\/doi.org\/10.1038\/s41419-025-07421-6","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,11]]},"assertion":[{"value":"10 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study on human lung adenocarcinoma specimens has been approved by the Institutional Review Board of Chung Shan Medical University Hospital (IRB CSMUH No: CS2-20206). Informed consent was obtained from all patients included in this study. The animal study was approved by the Institutional Animal Care and Utilization Committee of National Chung Hsing University, Taichung, Taiwan (Approval No: 109-111\u2009R).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"88"}}